Related Experiment Video
Updated: Mar 20, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.7K
Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects
Ramana Appireddy1, Charlotte Zerna1, Bijoy K Menon2
1Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Medical Centre, 1403 29th St NW, Calgary, AB, Canada.
Current Atherosclerosis Reports
|May 26, 2016
Summary
Endovascular thrombectomy is a proven treatment for acute ischemic stroke. Implementing this advanced stroke care globally presents challenges but offers future research opportunities.
Area of Science:
- Neurology
- Interventional Cardiology
- Vascular Surgery
Background:
- Acute ischemic stroke treatment has evolved significantly.
- Endovascular thrombectomy is now a cornerstone therapy.
- Evidence is primarily from specialized stroke centers.
Purpose of the Study:
- To review the evolution of evidence for endovascular thrombectomy.
- To discuss implementation challenges in global stroke care.
- To explore future research and innovation in stroke treatment.
Main Methods:
- Literature review of clinical research and trials.
- Analysis of evidence supporting endovascular thrombectomy.
- Discussion of global healthcare system integration.
Main Results:
- Endovascular thrombectomy is highly effective for acute ischemic stroke.
- Significant disparities exist in accessing this treatment.
- Implementation requires addressing logistical and expertise barriers.
Conclusions:
- Endovascular thrombectomy represents a major advancement in stroke care.
- Translating evidence into routine global practice is critical.
- Continued innovation is needed to optimize patient outcomes worldwide.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
459
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
01:27Peripheral Artery Disease III: Interprofessional Care
539
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539
01:28Acute Coronary Syndrome IV: Interprofessional Care
429
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
429
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
630
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
630
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K